Dr. Ramesh Daggubati, MD

Dr. Daggubati practices at WVU Medicine Uniontown Hospital in Uniontown, Pennsylvania, part of West Virginia University Health System.

Dr. Daggubati's NPI, 1083600522, was assigned on September 20, 2005. Dr. Daggubati holds New York license 222210.

Dr. Daggubati's primary practice is WVU Medicine Uniontown Hospital, at 500 West Berkeley Street, Uniontown, PA 15401 in Fayette County. The practice phone is (724) 430-5000.

Dr. Daggubati's primary practice is WVU Medicine Uniontown Hospital in Uniontown, Pennsylvania, part of West Virginia University Health System. Dr. Daggubati is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Dr. Daggubati to 4 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Daggubati practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Daggubati's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Daggubati's licenses on file in 2 states: New York and North Carolina.

CMS data shows 629 Medicare services from Dr. Daggubati across 17 procedure codes in 2024, for 406 Medicare patients. Medicare paid $115,280 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 406 Medicare patients who saw Dr. Daggubati in 2024. The largest group is 75 to 84, with 172 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Daggubati's median patient age at 75, with 40% women.

In 2024, Dr. Daggubati wrote 249 Medicare Part D claims for 114 patients. 74% of them were for generic drugs. CMS names the drug for 123 of them, across 4 drugs with 11 or more claims each, at $29,360 in total drug cost. In 2023, CMS named 113 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Daggubati for performance year 2024, reported through an alternative payment model (APM). Dr. Daggubati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Daggubati as offering telehealth. CMS counts 27 procedures of coronary angioplasty and stenting by Dr. Daggubati, more than 61% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 773 general payments to Dr. Daggubati from 41 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 36% of the total. Medtronic Vascular, Inc. paid the most, $103,416.